BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nalivaeva NN, Zhuravin IA, Turner AJ. Neprilysin expression and functions in development, ageing and disease. Mech Ageing Dev. 2020;192:111363. [PMID: 32987038 DOI: 10.1016/j.mad.2020.111363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim J, Ahn SW, Deans K, Thompson D, Ferland B, Divakar P, Dominas C, Jonas O. Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain. Front Bioeng Biotechnol 2022;10:855755. [DOI: 10.3389/fbioe.2022.855755] [Reference Citation Analysis]
2 Turner AJ, Nalivaeva NN. Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170766] [Reference Citation Analysis]
3 Garbuz DG, Zatsepina OG, Evgen’ev MB. Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis. Mol Biol 2021;55:670-82. [DOI: 10.1134/s002689332104004x] [Reference Citation Analysis]
4 Vijverberg EGB, Axelsen TM, Bihlet AR, Henriksen K, Weber F, Fuchs K, Harrison JE, Kühn-Wache K, Alexandersen P, Prins ND, Scheltens P. Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD. Alzheimers Res Ther 2021;13:142. [PMID: 34425883 DOI: 10.1186/s13195-021-00882-9] [Reference Citation Analysis]
5 Abramicheva PA, Plotnikov EY. Hormonal Regulation of Renal Fibrosis. Life 2022;12:737. [DOI: 10.3390/life12050737] [Reference Citation Analysis]
6 Mai L, He G, Chen J, Zhu J, Chen S, Hou X, Yang H, Zhang M, Wu Y, Lin Q, Yang M, Li X. Proteomic Analysis of Hypoxia-Induced Senescence of Human Bone Marrow Mesenchymal Stem Cells. Stem Cells Int 2021;2021:5555590. [PMID: 34484348 DOI: 10.1155/2021/5555590] [Reference Citation Analysis]
7 Burrinha T, Cláudia GA. Aging impact on amyloid precursor protein neuronal trafficking. Curr Opin Neurobiol 2022;73:102524. [PMID: 35303572 DOI: 10.1016/j.conb.2022.102524] [Reference Citation Analysis]
8 Yan X, Liu H, Hong Y, Meng T, Du J, Chang C. lncRNA XIST induces Aβ accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer’s disease. Journal of Neurogenetics. [DOI: 10.1080/01677063.2022.2028784] [Reference Citation Analysis]
9 Goldstein MR, Cheslock M. On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain. Med Hypotheses 2021;154:110645. [PMID: 34315048 DOI: 10.1016/j.mehy.2021.110645] [Reference Citation Analysis]
10 Berezin AA, Fushtey IM, Berezin AE. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients. JCDD 2022;9:23. [DOI: 10.3390/jcdd9010023] [Reference Citation Analysis]
11 Vasilev D, Dubrovskaya NM, Nalivaeva NN. Caspase Inhibition Restores NEP Expression and Rescues Olfactory Deficit in Rats Caused by Prenatal Hypoxia. J Mol Neurosci 2022. [PMID: 35344141 DOI: 10.1007/s12031-022-01986-z] [Reference Citation Analysis]
12 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. WJC 2021;13:326-40. [DOI: 10.4330/wjc.v13.i8.326] [Reference Citation Analysis]
13 Asadi M, Mohammadi-Khanaposhtani M, Hosseini FS, Gholami M, Dehpour AR, Amanlou M. Design, synthesis, and evaluation of novel racecadotril-tetrazole-amino acid derivatives as new potent analgesic agents. Res Pharm Sci 2021;16:341-57. [PMID: 34447443 DOI: 10.4103/1735-5362.319573] [Reference Citation Analysis]
14 Schreiner TG, Popescu BO. Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact. JCM 2021;10:5986. [DOI: 10.3390/jcm10245986] [Reference Citation Analysis]
15 Zhao Y, Bao J, Liu W, Gong X, Liang Z, Li W, Wu M, Xiao Y, Sun B, Wang X, Wang J, Wang J, Shu X, Gong C. Spatial Training Attenuates Long-Term Alzheimer’s Disease-Related Pathogenic Processes in APP/PS1 Mice. JAD 2021. [DOI: 10.3233/jad-215016] [Reference Citation Analysis]
16 Westmark CJ, Filon MJ, Maina P, Steinberg LI, Ikonomidou C, Westmark PR. Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model. Cells 2022;11:1350. [DOI: 10.3390/cells11081350] [Reference Citation Analysis]
17 Vasilev DS, Dubrovskaya NМ, Tumanova NL, Nalivaeva NN. Analysis of Expression of the Amyloid-Degrading Enzyme Neprilysin in Brain Structures of 5xFAD Transgenic Mice. J Evol Biochem Phys 2022;58:193-203. [DOI: 10.1134/s0022093022010173] [Reference Citation Analysis]
18 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325] [Reference Citation Analysis]
19 Bini L, Schvartz D, Carnemolla C, Besio R, Garibaldi N, Sanchez JC, Forlino A, Bianchi L. Intracellular and Extracellular Markers of Lethality in Osteogenesis Imperfecta: A Quantitative Proteomic Approach. Int J Mol Sci 2021;22:E429. [PMID: 33406681 DOI: 10.3390/ijms22010429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]